Jasper Ridge Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Jasper Ridge Partners’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,575	Closed	-$233K	–	152
2022 Q4	$233K	Buy	+15,575	New	+$216K	0.01%	119

Jasper Ridge Partners's AVEO Position: Q1 2023 in Review

Jasper Ridge Partners sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 15,575 shares — an estimated $233K sold.

Jasper Ridge Partners first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $233K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Jasper Ridge Partners reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Jasper Ridge Partners sold 15,575 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $233K.
Jasper Ridge Partners first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Jasper Ridge Partners's AVEO Pharmaceuticals, Inc. position peaked at $233K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Jasper Ridge Partners's 13F filing for Q1 2023, filed 15 May 2023.